Multiple Sclerosis News
News on Multiple Sclerosis continually updated from thousands of sources around the net.
9 hrs ago | ABC Action News
ST. PETE BEACH, Fla - It's a love story come full circle and a commitment anew, with an Indiana couple renewing their vows on St. Pete Beach right behind the Tradewinds resort on Sunday morning. ABC Action News first brought you Bart and Rachel Naylor's love story several months ago, when an engraved "Bart & Rachel" ring washed up along the beach.
Sanofi rare disease unit Genzyme hopes to become a leader in the multiple sclerosis field with the help of new products developed in-house but also through acquisitions, senior Genzyme executives told Reuters. The Cambridge, Massachusetts company is confident in the commercial success of its two MS drugs Lemtrada and Aubagio and is "very active" in its hunt for external growth, Bill Sibold, the head of Genzyme's MS franchise, told Reuters.
As a medium, the internet neither helps nor harms in multiple sclerosis care - what matters is how clinicians and patients engage in that medium, according to Paul Wicks, PhD, vice president of Innovation at PatientsLikeMe. His company is a Patient Powered Research Network, which are becoming increasingly common, he explained during his session at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.
Despite the benefit of having more choices than ever before to treat patients with multiple sclerosis , the abundance of options has led to more complexity, according to speakers at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts. In the 1980s just 1 option had been available, but there are currently 12 that patients and providers need to choose between when creating a treatment plan for individuals with MS.
John F. Kurtzke. Epidemiology in multiple sclerosis: a pilgrim's progress. Brain 2013: 136; 2904-17; doi:10.1093/brain/awt220.
Multiple Sclerosis is a neurological disorder that presents with myriad of symptoms. The disease causes physical as well as emotional changes in the patients.
Intrathecal oligoclonal bands of the cerebrospinal fluid are considered the most important immunological biomarkers of multiple sclerosis. They typically consist of clonally expanded IgG antibodies that underwent affinity maturation during sustained stimulation by largely unknown antigens.
The treatment landscape for multiple sclerosis continues to get more complex month to month, which makes biomarker discovery increasingly important for treating the disease, according to Suhayl Dhib-Jalbut, MD, professor at the Rutgers University Robert Wood Johnson Medical School. There are many significant reasons why biomarker discovery in MS is crucial, including early diagnosis, assessing disease activity, and predicting treatment response and treatment complications, Dhib-Jalbut said during his talk "Biomarkers of Treatment Response to MS Disease Therapies," at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston, Massachusetts from September 10-13.
The 23-year-old hails from Hartford, Kentucky and already has an inspiring journey on her way to multiple pageant crowns. Several years ago, Carpenter was diagnosed with Multiple Sclerosis.
Calgary researchers are recruiting patients for a clinical trial, as they try to find a drug that can repair the damage caused by relapsing and remitting forms of multiple sclerosis. "One of them is called domperidone," explains Dr. V Wee Yong, a neuroscientist with the Hotchkiss Brain Institute.
The fatigue many people with multiple sclerosis experience may actually be a sign of an undiagnosed sleep disorder, according to a new study. Researchers found that sleep disorders, which are more common among people with MS, are often left undiagnosed and untreated.
Fatigue is one of the most common symptoms in people with multiple sclerosis , and a major cause for this is sleep deprivation. Sleep deprivation, while common in MS patients, often goes undiagnosed, according to a large population-based study conducted on more than 2,300 individuals.
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion.
People with multiple sclerosis lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging study. Researchers said the findings could have important applications in clinical trials and treatment monitoring.
An early clinical trial testing the use of a patient's own stem cells to treat, or even reverse, multiple sclerosis has shown some positive results, Cleveland Clinic researchers reported this week. The Phase 1 trial , unique in the United States, tested the safety and feasibility of treating MS patients with a dose of their own adult mesenchymal stem cells , or MSCs.
Kessler Foundation scientists have shown that working memory may be an underlying mechanism of cognitive reserve in multiple sclerosis . This finding informs the relationships between working memory, intellectual enrichment and long-term memory in this population.
Updated: Sun Sep 14, 2014 05:44 pm
Copyright © 2014 Topix LLC